| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |